Definium Therapeutics, Inc. Ttl Offering Amt
Definium Therapeutics, Inc. (DFTX) had Ttl Offering Amt of $805.00 million as of 2026-06-24, per its 424B5 filed 2026-06-24.
Financial Statements › Notes
ffd:TtlOfferingAmt · last filed 2026-06-24
- 2026-06-24: Ttl Offering Amt $805.00M.
| Period end | Ttl Offering Amt |
|---|---|
| 2026-06-24 | $805.00M 424B5 · filed 2026-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |